The Frazer Institute is a modern research facility where clinical and basic science are used to study cancer, immunology and genomic medicine. The Institute has a vibrant community of over 300 researchers, students and support staff. We have delivered global, worldchanging discoveries such as:

  • Discovery, development and release of the world’s first cervical cancer vaccine.
  • Identification of genes responsible for one-third of the risk of developing ankylosing spondylitis.
  • Development of a new test to identify patients with the potential to develop diabetes.
  • Development of new ways of identifying melanoma. 
  • Identification of new markers for blood cancer.
  • Identification of new genes involved in osteoporosis, birth weight and other complex genetic traits.
  • Clinical trial for the world’s first rheumatoid arthritis treatment.

The Frazer Institute has a strong history of commercialising early-stage technologies and successfully translating these to the clinic. 

Commercial activities undertaken at the Frazer Institute include:

  • Intellectual property management
  • Industry partnerships
  • Development of a range of Frazer Institute technologies

For further information, please contact our Research Partnerships Manager or visit UniQuest.